NCT07518264

Brief Summary

This study aims to preliminarily explore the intervention effect and feasibility of group natural psychotherapy (a new Eastern culture-based psychotherapy method) for patients with anxiety disorder through a randomized controlled trial.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Mar 2026Jul 2026

Study Start

First participant enrolled

March 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

April 2, 2026

Last Update Submit

April 2, 2026

Conditions

Keywords

Obsessive - Compulsive DisorderNatural Psychotherapy

Outcome Measures

Primary Outcomes (2)

  • Generalized Anxiety Disorder-7 (GAD-7)

    The GAD-7 is a brief self-report questionnaire designed to assess the severity of generalized anxiety symptoms (Spitzer et al., 2006). It consists of seven items, with higher scores indicating greater severity of anxiety. Clinical cut-off scores are: 0-4 (minimal/no clinical anxiety), 5-9 (mild), 10-14 (moderate), and ≥ 15 (severe). The Chinese version of the GAD-7 has demonstrated good reliability and validity, with high internal consistency (Cronbach's α = 0.93) and satisfactory test-retest reliability (ICC = 0.71-0.87; Zhang et al., 2021).

    week 0; week 4; week 8

  • State-Trait Anxiety Inventory (STAI)

    The STAI consists of two subscales (Spielberger et al., 1970): the State Anxiety Inventory (S-Anxiety, Items 1-20) and the Trait Anxiety Inventory (T-Anxiety, Items 21-40). The S-Anxiety subscale reflects transient feelings of tension, apprehension and nervousness in response to stressors, while the T-Anxiety subscale assesses relatively stable individual differences in anxiety proneness. Both subscales use a 4-point Likert scale (total scores 20-80), with higher scores indicating higher levels of anxiety; certain items are reverse-scored. The Chinese version shows robust reliability and validity, with high internal consistency (Cronbach's α = 0.91-0.92), strong test-retest reliability (0.76-0.91), and significant correlations with the HAMA (r = 0.69-0.74; Ma et al., 2012).

    week 0; weeek 4; week 8

Secondary Outcomes (2)

  • Intolerance of Uncertainty Scale (IUS)

    week 0; weeek 4; week 8

  • Quality of Life Scale (QOL)

    week 0; weeek 4; week 8

Other Outcomes (3)

  • Revised Beads Task

    week 0; weeek 4

  • Emotional Color-word Stroop

    week 0; weeek 4

  • Resting-state functional Magnetic Resonance Imaging (fMRI)

    week 0; week 4

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants will undergo baseline assessment (T0) prior to the intervention, followed by a 4 week Natural Psychotherapy treatment in group setting. The group therapy will be delivered once per week, with each session lasting 2-3 hours. Post-intervention assessment (T1) will be conducted immediately after the completion of the intervention, and a follow-up assessment will be carried out 1 month after treatment termination (T2).

Behavioral: Group-based Natural Psychotherapy

Waiting-list control group

NO INTERVENTION

Participants in the control group will receive baseline assessments prior to the waiting period and will continue their treatment-as-usual (TAU) while being placed on a waiting list for 4 weeks. Post-waiting assessment (T1) will be conducted at the end of the waiting period. After T1, the control group patients will receive the same group therapy as the intervention group.

Interventions

Patients will be divided into 3-4 groups, with each group comprising 8-10 patients, led by one psychotherapist. The intervention will last 4 weeks, with all patients required to participate in weekly face-to-face group sessions, each lasting 2-3 hours. The weekly group sessions are the core of the treatment and consists of two parts: (1) phase-specific psychoeducation on the theoretical principles of Natural Psychotherapy; (2) experiential learning through carefully designed activities to facilitate personal experience and understanding of the theoretical content. Homework is assigned after each group session, such as writing treatment diaries and daily exercise plans. The psychotherapists review patients' treatment diaries daily according to guiding principles and provide feedback, offering key guidance and support. Exercise is emphasized as a core component of active action within the Natural Psychotherapy; participants will develop personalized weekly exercise plans during group ses

Intervention group

Eligibility Criteria

Age15 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Meet the diagnostic criteria for anxiety disorders in the DSM - 5;
  • Aged between 15 and 55 years old;
  • Have a junior high school education or above;
  • The patient agrees to participate in this project and signs the informed consent form.

You may not qualify if:

  • Have comorbidities of other severe mental disorders (including schizophrenia, bipolar disorder, and major depressive disorder);
  • Have a lifetime history of substance abuse;
  • Patients with severe neurological diseases, mental retardation, and cognitive impairment;
  • At high risk of suicide or have suicidal behavior;
  • Pregnant or breastfeeding;
  • Have severe physical diseases and infectious diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Natural Psychotherapy

Hefei, Anhui, 230000, China

Location

MeSH Terms

Conditions

Compulsive Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
In the study, primary clinical outcomes were evaluated using self - rating scales.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 8, 2026

Study Start

March 1, 2026

Primary Completion

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-03

Locations